Assetmark »

Catalyst Pharmaceutical Partners shares owned by Assetmark

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Assetmark

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 69k 15.94
2023-12-31 $1.1M 65k 16.81
2023-09-30 $727k 62k 11.69
2023-06-30 $752k 56k 13.44
2023-03-31 $962k 58k 16.58
2022-12-31 $1.1M 58k 18.60
2022-09-30 $759k 59k 12.84

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Bloomberg High Y (JNK)

View all positions for Assetmark

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners